Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

2’-O-methyl-phosphorothioate oligonucleotide

EU orphan designation number: EU/3/06/357
Active ingredient: 2’-O-methyl-phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Prosensa B.V.
Einsteinweg 55, 2333 CC Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Orphan designation EMEA/OD/096/05 (2006)550 of 16/02/2006
03/03/2009 Removal of orphan designation from Community Register